alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Order entered October 30, 2014

In The

Court of Appeals 

Fifth District of Texas at Dallas 

No. 05-14-00564-CR

ROGER ALLEN STULCE, JR, Appellant

V.

THE STATE OF TEXAS, Appellee

On Appeal from the 380th Judicial District Court

Collin County, Texas

Trial Court Cause No. 380-82427-2012

ORDER

The Court ORDERS the trial court to conduct a hearing to determine why appellant’s 

brief has not been filed. In this regard, the trial court shall make appropriate findings and 

recommendations and determine whether appellant desires to prosecute the appeal, whether 

appellant is indigent, or if not indigent, whether retained counsel has abandoned the appeal. See

TEX. R. APP. P. 38.8(b). If the trial court cannot obtain appellant’s presence at the hearing, the 

trial court shall conduct the hearing in appellant’s absence. See Meza v. State, 742 S.W.2d 708 

(Tex. App.–Corpus Christi 1987, no pet.) (per curiam). If appellant is indigent, the trial court is 

ORDERED to take such measures as may be necessary to assure effective representation, which 

may include appointment of new counsel.
We ORDER the trial court to transmit a record of the proceedings, which shall include 

written findings and recommendations, to this Court within THIRTY DAYS of the date of this 

order.

This appeal is ABATED to allow the trial court to comply with the above order. The 

appeal shall be reinstated thirty days from the date of this order or when the findings are 

received, whichever is earlier.

/s/ ADA BROWN 

JUSTICE
```

[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H. Con. Res. 25 Received in Senate (RDS)]

<DOC>
118th CONGRESS
  1st Session
H. CON. RES. 25

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                             March 27, 2023

                                Received

_______________________________________________________________________

                         CONCURRENT RESOLUTION

 
Authorizing the use of Emancipation Hall in the Capitol Visitor Center 
for a ceremony as part of the commemoration of the days of remembrance 
                      of victims of the Holocaust.

    Resolved by the House of Representatives (the Senate concurring),

SECTION 1. USE OF EMANCIPATION HALL FOR A CEREMONY AS PART OF THE 
              COMMEMORATION OF THE DAYS OF REMEMBRANCE OF VICTIMS OF 
              THE HOLOCAUST.

    (a) Authorization.--Emancipation Hall in the Capitol Visitor Center 
is authorized to be used on April

              

 20, 2023, for a ceremony as part of the commemoration of the days of 
remembrance of victims of the
Holocaust.
    (b) Preparations.--Physical preparations for the ceremony described 
in subsection (a) shall be carried out in accordance with such 
conditions as the Architect of the Capitol may prescribe.

            Passed the House of Representatives March 24, 2023.

            Attest:

                                             CHERYL L. JOHNSON,

                                                                 Clerk.
```
Harry Meyer KATZ, petitioner, v. UNITED STATES.

No. 12-1326.

Supreme Court of the United States

June 10, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Eighth Circuit denied.
Bruce ERVIN, petitioner, v. ILLINOIS.

No. 12-9608.

Supreme Court of the United States

June 10, 2013.

Petition for writ of certiorari to the Appellate Court of Illinois, First District, denied.
IN THE UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF INDIANA

SOUTH BEND DIVISION

THOMAS LEGG, JR., )

)

Plaintiff, )

)

v. ) Cause No. 3:12-CV-844-JTM-CAN

)

NEW ENGLAND COMPOUNDING )

PHARMACY, INC. a/k/a NEW )

ENGLAND COMPOUNDING CENTER; )

AMERIDOSE, LLC; ALAUNUS )

PHARMACEUTICAL, LLC; BARRY )

CADDEN; LISA CADDEN; )

and GREGORY CONIGLIARO, )

)

Defendants. )

DEFENDANT ALAUNUS PHARMACEUTICAL, LLC’S 

CORPORATE DISCLOSURE 

Defendant Alaunus Pharmaceutical, LLC, by counsel, pursuant to Federal Rule of Civil 

Procedure 7.1, makes the following corporate disclosure: Alaunus Pharmaceutical, LLC does 

not have any parent corporations and no publicly-held corporation owns 10% or more of 

Alaunus’s stock.

LEWIS WAGNER LLP

By: /s/ Kameelah Shaheed-Diallo

DINA M. COX, #18590-49

KAMEELAH SHAHEED-DIALLO, #28058-49

ROBERT M. BAKER IV, #25471-49

Attorneys for Defendants New England 

Compounding Pharmacy Inc.; Alaunus 

Pharmaceutical, LLC; Barry Cadden; Lisa Cadden; 

and Gregory Conigliaro

case 3:12-cv-00844-JTM-CAN document 9 filed 01/04/13 page 1 of 2
2

CERTIFICATE OF SERVICE

This is to certify that a copy of the foregoing has been filed with the Clerk of the Court 

on January 4, 2013 using the CM/ECF system which sent notification of this filing to the 

following: 

Douglas A. Mulvaney

STUTSMAN & MULVANEY

1300 Cassopolis Street

P.O. Box 1337

Elkhart, Indiana 46515

/s/ Kameelah Shaheed-Diallo

KAMEELAH SHAHEED-DIALLO

LEWIS WAGNER, LLP

501 Indiana Avenue, Suite 200

Indianapolis, IN 46202

Phone: (317) 237-0500

FAX: (317) 630-2790

kshaheed-diallo@lewiswagner.com

Q:\NECC\15 - Legg\Federal Court Action\Corporate Disclosure_Alaunus.docx

case 3:12-cv-00844-JTM-CAN document 9 filed 01/04/13 page 2 of 2
Stephen HARRIS, petitioner, v. BRADLEY MEMORIAL HOSPITAL AND HEALTH CENTER, INC.

No. 12-916.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the Supreme Court of Connecticut denied.
Protege a todos al no trabajar cuando estes enfermo.

Antes de ir a trabajar pregúntate: ¿Me siento bien hoy?
Anthony CAPPELLETTI, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D19-0711

District Court of Appeal of Florida, Second District.

June 25, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
Shamel A. THOMAS, Appellant, v. STATE of Florida, Appellee.

Case No. 2D18-2729

District Court of Appeal of Florida, Second District.

Opinion filed June 19, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
Jesse Joe GUTIERREZ, applicant, v. UNITED STATES.

No. 12A886.

Supreme Court of the United States

April 22, 2013.

Application for stay addressed to Justice BREYER and referred to the Court denied.
Joel RODRIGUEZ, Appellant, v. The STATE of Florida, Appellee.

No. 3D18-2408

District Court of Appeal of Florida, Third District.

Opinion filed April 24, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Affirmed.
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta name="pdf:PDFVersion" content="1.2">
<meta name="xmp:CreatorTool" content="Acrobat Capture Server 2.0">
<meta name="pdf:hasXFA" content="false">
<meta name="access_permission:modify_annotations" content="true">
<meta name="dc:creator" content="capture">
<meta name="dcterms:created" content="1998-09-02T19:39:32Z">
<meta name="dcterms:modified" content="1998-09-02T19:39:35Z">
<meta name="dc:format" content="application/pdf; version=1.2">
<meta name="pdf:docinfo:creator_tool" content="Acrobat Capture Server 2.0">
<meta name="access_permission:fill_in_form" content="true">
<meta name="pdf:docinfo:modified" content="1998-09-02T19:39:35Z">
<meta name="pdf:hasCollection" content="false">
<meta name="pdf:encrypted" content="false">
<meta name="Content-Length" content="68454">
<meta name="pdf:hasMarkedContent" content="false">
<meta name="Content-Type" content="application/pdf">
<meta name="access_permission:can_print_faithful" content="true">
<meta name="pdf:docinfo:creator" content="capture">
<meta name="pdf:producer" content="Acrobat PDFWriter 3.02 for Windows NT">
<meta name="access_permission:extract_for_accessibility" content="true">
<meta name="access_permission:assemble_document" content="true">
<meta name="xmpTPg:NPages" content="2">
<meta name="pdf:hasXMP" content="false">
<meta name="access_permission:extract_content" content="true">
<meta name="access_permission:can_print" content="true">
<meta name="X-TIKA:Parsed-By" content="org.apache.tika.parser.DefaultParser">
<meta name="X-TIKA:Parsed-By" content="org.apache.tika.parser.pdf.PDFParser">
<meta name="access_permission:can_modify" content="true">
<meta name="pdf:docinfo:producer" content="Acrobat PDFWriter 3.02 for Windows NT">
<meta name="pdf:docinfo:created" content="1998-09-02T19:39:32Z">
<title></title>
</head>
<body><div class="page"><p></p>
<p>. . . 
</p>
<p>OFFICE OF THE ATTORNEY GENERAL OF TEXAS 
</p>
<p>AUSTIN 
</p>
<p>Q- c huwu 
IwosaNonl- </p>
<p></p>
</div>
<div class="page"><p></p>
<div class="ocr">Momerable Bert Ford, Aduinistrater, page 2
of Pubite Walfare, copy of which we band you herewith.
Very truly yours
ATTOANSY GHESKAL OF TAXAS
LETROVES APR 1Z, 1942 - . :
eur A
Me wy Sisal
issis
OG-MR
Sncloaure
a a

COMMITTEES

Yo ;
\ BY, —— a
4 CHAIRMAL
“
“ne,

</div>

</div>
</body></html>
SMG 1119A.6 (12/14/2018) 1

SMG 1119A.6

FDA Staff Manual Guides, Volume I – Organizations and Functions

Department of Health and Human Services

Food and Drug Administration

Office of the Commissioner

Office of the Chief Scientist

Office of Scientific Professional Development

Effective Date: December 14, 2018

1. Office of Scientific Professional Development (DCPE).

A. Supports scientific and technical excellence and the professional development of 

Food and Drug Administration (FDA) scientists in all areas and as such strives to 

provide comprehensive scientific and technical opportunities to FDA staff, 

Students, Fellows and Trainees.

B. Directs, establishes and manages scientific professional development programs

in order to assure the highest level of competence among FDA scientific and 

technical staff through programs that are designed to recruit, train and retain 

FDA’s next generation scientific staff. Programs under the purview of this office 

include: the Commissioner’s Fellowship, FDA/NCI IOTF Fellowship, ORISE 

Fellowship and FDA Traineeship.

C. Establishes and manages training activities for students, Fellows and trainees to 

include serving as a liaison to the FDA Fellows Association.

D. Manages clinical and scientific educational activities providing Agency-wide 

continuing education for FDA clinical staff to include access to university and 

National Institutes of Health (NIH) opportunities for CME and other continuing 

education, and enhanced opportunities for clinical and professional 

engagements.

E. Manages FDA scientific retention programs to reward scientists such as scientific 

achievement awards.

F. Supports and enhances FDA-wide professional development policies and 

programs by formulating the base policies and operational philosophy, by 
SMG 1119A.6 (12/14/2018) 2

collaborating with Centers to implement FDA “best practices” and by promoting 

exchange of resources and opportunities among Centers.

G. Supports the coordination of FDA activities related to the peer review of scientists 

and medical officers.

2. Authority and Effective Date.

The functional statements for the Office of Scientific Professional Development were 

approved by the Secretary of Health and Human Services and effective on 

December 14, 2018.

Back to Organizations and Functions, Volume I (1000-1300)

Staff Manual Guide 1119A.6

Organizations and Functions

Effective Date: December 14, 2018

The following is the Department of Health and Human Services, Food and Drug 

Administration, Office of the Chief Scientist, Office of Scientific Professional 

Development organization structure depicting all the organizational structures reporting 

to the Director.

Office of Scientific Professional Development (DCPE)
[PROPOSED] FINAL ORDER OF FORFEITURE

CR 16-0491 BLF 1

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

SAN JOSE DIVISION

UNITED STATES OF AMERICA,

Plaintiff,

v.

EDWIN ADRIAN ARROYO-RIVERA,

Defendant.

)

)

)

)

)

)

)

)

)

)

CASE NO.: CR 16-0491 BLF

[PROPOSED] FINAL ORDER OF 

FORFEITURE

On February 21, 2018, this Court entered a Preliminary Order of Forfeiture forfeiting the 

following property as to Edwin Adrian Arroyo-Rivera, pursuant to Title 21, United States Code, Section 

853 and the procedures outlined in Rule 32.2 of the Federal Rules of Criminal Procedure:

• $12,627 in cash seized from the detached garage at 633 Cedar Avenue, Wasco, California on 

December 6, 2016

The United States represents that it has complied with the publication and other notice 

requirements of the Preliminary Order. One petition was filed during the claims period. That petition 
[PROPOSED] FINAL ORDER OF FORFEITURE

CR 16-0491 BLF 2 

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

was filed by Martin Violante Lopez and claimed $8,900 of the above listed money. The United States 

has reviewed that petition, its supporting documents, and other evidence in the case, and the United 

States does not oppose the petition. 

THEREFORE, IT IS HEREBY ORDERED that $8,900 of the above-described property shall 

be released to the petitioner and claimant in this matter, Martin Violante Lopez.

IT IS FURTHER ORDERED that the remaining amount of the above described property shall 

be forfeited to the United States pursuant Title 21, United States Code, Section 853 and the procedures 

outlined in Rule 32.2 of the Federal Rules of Criminal Procedure, and that all rights, title, and interest in 

that property is vested in the United States of America. The remaining amount is calculated as $3,727. 

The appropriate federal agency shall dispose of the forfeited property according to law. 

 

Dated: _______________________________ 

 BETH LABSON FREEMAN

United States District Judge

0D\
**
**EXHIBIT 31**

**CERTIFICATIONS**

I, Ron Hooper, certifythat: 

1. I have reviewed this quarterly report on Form 10-Q of Sabine Royalty Trust,for which Simmons Bank acts as Trustee; 

2. Based on my knowledge, this report does not contain any untrue statement of a materialfact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in allmaterial respects the financial condition, distributable income and changes in trust corpus of the registrant as of, and for, the periods presented in this report; 

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(c)and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), or for causing such controls and proceduresto be established and maintained, for the registrant and I have: 

a) Designed such disclosure controls andprocedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within thoseentities, particularly during the period in which this report is being prepared; 

b) Designed such internal controlover financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements forexternal purposes; 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures andpresented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurredduring the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controlover financial reporting; and 

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting,to the registrant’s auditors: 

a) All significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in theregistrant’s internal control over financial reporting. 

 
By: /s/ Ron Hooper
Ron Hooper

SVP, Royalty Trust Management

Simmons Bank

Date: August 11, 2022 
**
1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

United States District Court

Northern District of California

UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF CALIFORNIA

FRANCISCA MORALEZ,

Plaintiff,

v.

HILLSTONE RESTAURANT GROUP, 

INC., et al.,

Defendants.

Case No. 17-cv-00665-WHO 

ORDER OF DISMISSAL

Re: Dkt. No. 14

Pursuant to notice of voluntary dismissal, IT IS HEREBY ORDERED that this case is 

dismissed with prejudice. The Clerk shall close the case. 

Dated: June 2, 2017

______________________________________

WILLIAM H. ORRICK

United States District Judge
Johnny OLBEL, petitioner, v. UNITED STATES.

No. 12-9219.

Supreme Court of the United States

April 15, 2013.

Petition for writ of certiorari to the United States Court of Appeals for the Eleventh Circuit denied.
Kevin Robert SHIRLEY, Appellant, v. STATE of Florida, Appellee.

Case No. 5D17-2599

District Court of Appeal of Florida, Fifth District.

Opinion filed June 21, 2019

James S. Purdy, Public Defender, and Thomas J. Lukashow, Assistant Public Defender, Daytona Beach, for Appellant.

Ashley Moody, Attorney General, Tallahassee, and Deborah A. Chance, Assistant Attorney General, Daytona Beach, for Appellee.

PER CURIAM.

Affirmed without prejudice to raise any claim of ineffective assistance of counsel in a timely motion for postconviction relief filed pursuant to Florida Rule of Criminal Procedure 3.850. *See**Greene v. State* , 220 So. 3d 454 (Fla. 5th DCA 2016).

AFFIRMED.

BERGER, EDWARDS and SASSO, JJ., concur.
Eugene Jermaine BETTS, Appellant/Petitioner(s), v. STATE of Florida, Appellee/Respondent(s).

CASE NO.: 2D19-1447

District Court of Appeal of Florida, Second District.

July 17, 2019

**DECISION WITHOUT PUBLISHED OPINION**

Denied.
oak Call) gay (IE atl a dia oi) ale al CaS BB int yg aS Case gc Cyny Chadd aad Jat) Cals Lada y ALI tal GB cod pan
plsLalall ol! atl yal) lll Lb Gay Goa CIS gl) yt) Mala GH colgall 898 cal} ae ual Gz pally
CO) Cad des ub Lase) Gi Ugale GIs

NUE ati gi clay dati

8G G2 yay GUS) Cael (plLaN gall (8 CMGY Ugenal 5 pata BU Gael Gye ASS] (gl) ADL Gab GIS...

eh oly Banal Gb Clalit Gi gana
us Gaal aL AVI Gil oe ual ll gh

wagall Va Gf plabl slac) cleats

ptdduly chy Jae Sa ds cot Cull Aula abla:
aye Cail g fatal art Y cA gubdcall Cal gt) 9) cal jLAaN

wal Gagae edad Gi aeUbind Gf ls
United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

WAYMO LLC,

Plaintiff,

 v.

UBER TECHNOLOGIES, INC.;

OTTOMOTTO LLC; and OTTO

TRUCKING LLC,

Defendants. /

No. C 17-00939 WHA

ORDER SHORTENING TIME

TO BRIEF MOTION FOR

RELIEF

On August 28, Magistrate Judge Jacqueline Corley ruled from the bench to quash a

subpoena issued by defendant Otto Trucking LLC to non-party Keker, Van Nest & Peters LLP

(see Dkt. No. 1414 at 16:7–9). Otto Trucking has filed a motion for relief from that order

pursuant to Civil Local Rule 72 (Dkt. No. 1522). The deadline for responses is advanced from

September 25 to SEPTEMBER 14 AT NOON. The deadline for any reply is advanced from

October 2 to SEPTEMBER 15 AT NOON.

IT IS SO ORDERED.

Dated: September 12, 2017. WILLIAM ALSUP

UNITED STATES DISTRICT JUDGE

Case 3:17-cv-00939-WHA Document 1531 Filed 09/12/17 Page 1 of 1
EX-31 Rule 13a-14(d)/15d-14(d) Certification.


  I, Kristen Ann Cronin, certify that:

  1. I have reviewed this report on Form 10-K and all reports on Form 10-D
     required to be filed in respect of the period covered by this report on
     Form 10-K of ACE Securities Corp. Home Equity Loan Trust, Series
     2007-SL2 (the "Exchange Act periodic reports");

  2. Based on my knowledge, the Exchange Act periodic reports, taken as a
     whole, do not contain any untrue statement of a material fact or omit
     to state a material fact necessary to make the statements made, in
     light of the circumstances under which such statements were made, not
     misleading with respect to the period covered by this report;

  3. Based on my knowledge, all of the distribution, servicing and other
     information required to be provided under Form 10-D for the period
     covered by this report is included in the Exchange Act periodic reports;

  4. I am responsible for reviewing the activities performed by the
     servicers and based on my knowledge and the compliance reviews
     conducted in preparing the servicer compliance statements required in
     this report under Item 1123 of Regulation AB, and except as disclosed
     in the Exchange Act periodic reports, the servicers have fulfilled
     their obligations under the servicing agreements in all material
     respects; and

  5. All of the reports on assessment of compliance with servicing criteria
     for asset-backed securities and their related attestation reports on
     assessment of compliance with servicing criteria for asset-backed
     securities required to be included in this report in accordance with
     Item 1122 of Regulation AB and Exchange Act Rules 13a-18 and 15d-18
     have been included as an exhibit to this report, except as otherwise
     disclosed in this report.  Any material instances of noncompliance
     described in such reports have been disclosed in this report on Form
     10-K.

    In giving the certifications above, I have reasonably relied on
    information provided to me by the following unaffiliated parties: GMAC
    Mortgage, LLC as Servicer and Ocwen Loan Servicing, LLC as Servicer.

    Dated:   March 31, 2008


    /s/ Kristen Ann Cronin
    Signature

    Vice President
    (senior officer in charge of the servicing function of the master
    servicer)
1

IN THE UNITED STATES DISTRICT COURT

NORTHERN DISTRICT OF INDIANA

SOUTH BEND DIVISION

NANCY ISLAS, )

)

Plaintiff, )

) Case No: 3:12-cv-00845-WCL-CAN

-vs- )

)

NEW ENGLAND COMPOUNDING )

PHARMACY, INC., ET al. )

)

Defendants. )

NOTICE OF APPEARANCE

To the Clerk of this Court and all parties of record:

I, the undersigned, state that I have read the Standards of Professional Conduct within the 

Seventh Federal Judicial Circuit and the Local Rules of the U.S. District Court for the Northern 

District of Indiana pursuant to N.D.Ind.L.R. 83.5 (g) and Appendix B of this court and will 

faithfully adhere to them. I declare under the penalty of perjury that the foregoing is true and 

correct.

Please enter my appearance as counsel for plaintiff Nancy Islas.

Dated this 15th day of January, 2013.

Respectfully submitted,

/s/ Douglas A. Mulvaney

Douglas A. Mulvaney, # 10263-20

Stutsman & Mulvaney

1300 Cassopolis Street

P.O. Box 1337

Elkhart, IN 46515

(574) 266-8500

dmulvaney@smspilawyers.com

case 3:12-cv-00845-WCL-CAN document 14 filed 01/15/13 page 1 of 2
2

CERTIFICATE OF SERVICE

I hereby certify that on January 15, 2013, a true and complete copy of the above and 

foregoing served on: 

Dina M. Cox

Kameelah Shaheed-Diallo

Robert M. Baker, IV

LEWIS WAGNER, LLP

501 Indiana Avenue, Ste. 200

Indianapolis, IN 46202

/s/ Douglas A. Mulvaney

Douglas A. Mulvaney

case 3:12-cv-00845-WCL-CAN document 14 filed 01/15/13 page 2 of 2